Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy

BACKGROUND: Advanced ovarian cancer is treated with cytoreductive surgery and combination platinum- and taxane-based chemotherapy. Although most patients have acute clinical response to this strategy, the disease ultimately recurs. In this work we questioned whether the synthetic steroid mifepriston...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyeneche, Alicia A, Telleria, Carlos M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381704/
https://www.ncbi.nlm.nih.gov/pubmed/22642877
http://dx.doi.org/10.1186/1471-2407-12-200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381704/
https://www.ncbi.nlm.nih.gov/pubmed/22642877
http://dx.doi.org/10.1186/1471-2407-12-200

Ejemplares similares